Patient Education
Share your love
Top 12 Gene Therapies for Eye Diseases and Blindness
In a groundbreaking era of medical research, scientists and clinicians are spearheading novel gene therapies that hold promise for transforming the landscape of eye disease treatment. These cutting-edge interventions address a spectrum of conditions ranging from Usher Syndrome and retinoschisis…
2023 Recap: Top 15 Ophthalmic Medical Devices
In a groundbreaking year for ophthalmic advancements, 2023 has witnessed the launch of cutting-edge medical devices that promise to reshape the landscape of eye care. From augmented reality headsets to innovative surgical systems, the field is experiencing a wave of…
GRF Allocates $2.5M Grant for Glaucoma Research
The Glaucoma Research Foundation (GRF) announced an unprecedented $2.5 million allocation in annual research grants, marking the most significant investment in its 46-year history dedicated to pioneering efforts towards treating glaucoma and vision loss. Understanding Glaucoma and Its Impact Glaucoma…
MediPrint Finalizes Glaucoma Contact Lens Study
MediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the efficacy of its innovative product, LL-BMT1, against a control group using bimatoprost 0.01% ophthalmic solution. LL-BMT1, a preservative-free, weekly drug-eluting contact lens, utilizes the company’s 3D printing technology,…
Vital Tears Names Joseph Tauber, MD as CMO
Vital Tears, known for its innovative autologous serum tears, is excited to announce the appointment of Joseph Tauber, MD, to the role of Chief Medical Officer (CMO). This strategic addition aims to fortify the company’s commitment to leading-edge research, physician…
Pediatric Cataract Surgery Restores Vision for Infant
Nethradhama Super Speciality Eye Hospitals achieved a remarkable feat in pediatric eye care with the successful completion of a high-risk paediatric cataract surgery on an 8-month-old baby in Bangalore. Led by Dr. Sri Ganesh, a distinguished eye surgeon and the…
Glaukos’ iDose TR Hits the Commercial Market
Glaukos Corporation’s iDose TR, using Celanese’s VitalDose EVA (Ethylene Vinyl Acetate), to provide sustained drug release for the treatment of glaucoma has officially entered the commercial market. Having received FDA approval in December, iDose TR represents a notable departure from…
Faster, Cheaper 3D Printing for Artificial Eyeballs
A team of biomedical and ophthalmological researchers from various European institutions, in collaboration with computer graphics specialists, has unveiled a novel technique for 3D printing artificial eyeballs. Published in the esteemed journal Nature Communications, their innovative approach promises to revolutionize…
CoFi Collaborates with CareCredit to Expand Payment Solutions
CoFi, Inc., a leading provider of innovative payment software platforms for eye care practices, announced the market-wide availability of its multi-provider financing solution in collaboration with CareCredit, a Synchrony solution. The announcement marks a significant milestone in CoFi’s mission to…
CorNeat Vision Introduces CorNeat EverPatch in the U.S.
CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…